http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2015000887-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d65d3e9a44623b20bd8b02645a131aaa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-718
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-718
filingDate 2015-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96169aa5ce22ae2a2862aa7fd9e085a9
publicationDate 2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2015000887-A
titleOfInvention FORMULATION OF BISMUTE SUBGALATE.
abstract The present invention provides a bismuth subgalate formulation that can be used as a hemostatic agent in surgeries; more particularly, in otolaryngology for hemostasis after adenotonsilectomy (adenoamigdalectomy).
priorityDate 2015-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501462

Total number of triples: 16.